Effectiveness of Dexamethasone for COVID-19 in Hospitalized Patients With Diabetes: A Retrospective Cohort Study
Dexamethasone treatment did not significantly improve survival or time to clinical improvement in patients with diabetes and COVID-19 infection. Further prospective studies are needed to confirm these findings and determine potential mechanisms.
Authors
- Brian T. Garibaldi (ORCID: https://orcid.org/0000-0001-8632-5567)
- Jiajun Wu
- Salman Zahoor Bhat (ORCID: https://orcid.org/0000-0003-0304-4044)
- Nestoras Mathioudakis (ORCID: https://orcid.org/0000-0002-0210-655X)
- Kunbo Wang (ORCID: https://orcid.org/0000-0002-7850-5928)
- Jamie Perin (ORCID: https://orcid.org/0000-0002-5482-6620)
- Matthew L. Robinson (ORCID: https://orcid.org/0000-0003-0376-8560)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1210/clinem/dgae734
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39